AstraZeneca PLC (LSE:AZN) - Share price - Overview

Not a customer yet?

Buy shares from £4.95 with our easy-to-use SIPPs, ISAs and Dealing accounts

Find out more

Stock Report

AstraZeneca PLC AZN

Last Price
GBX5,502.00

Day Change
68.00|1.25%

As of 13/07/2018
18:38:33 BST | GBX
Minimum 15 Minutes Delay.

Last Close5,434.00p
Day Range5,479.00 - 5,536.00
Mkt Cap69.69Bil
52-Wk Range4,260.00 - 5,536.00
Yield %0.00
ISINGB0009895292
Volume2,669,812
P/E3,784.04
P/S3.10
P/CF19.48

Share Price

Total Returns 13/07/2018

 Chg (%)  
More ...
AstraZeneca PLC2.67 
FTSE 100 TR GBP-0.36
 
Financials
201520162017
More ...
Income Statement
Turnover24,708.0023,002.0022,465.00
Operating Profit3,132.003,572.002,052.00
Net Profit2,826.003,406.002,868.00
Reported EPS2.232.762.37
Balance Sheet
Current Assets16,007.0013,262.0013,150.00
Non Current Assets44,049.0049,264.0050,204.00
Total Assets60,056.0062,526.0063,354.00
Current Liabilities14,869.0015,256.0016,383.00
Total Liabilities41,547.0045,857.0046,712.00
Total Equity18,509.0016,669.0016,642.00
Cash Flow
Operating Cash Flow4,678.004,557.004,032.00
Net Change in Cash-37.00-1,148.00-1,686.00

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
27/03/2018Transfer inMr. Marc Dunoyer0.003,7680.00
27/03/2018Transfer inMr. Pascal Soriot0.0011,9980.00
02/02/2018PurchasePhilip A J Broadley4,846.3641520,112.00
13/12/2017Transfer outMr. Pascal Soriot0.0039,6480.00

Company Profile

AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.

Sector

Drug Manufacturers - Major

Index

FTSE 100 ,FTSE 350 ,FTSE All Share ,FTSE Eurotop 100 ,FTSE Eurotop 300

Next Event 26/07/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)31.10
Div Yld (E)3.85
PEG (E)7.80
ROCE6.26
Op Mrgn0.09
EPS Grwth-0.18
Dividends
PreviousLatest
More ...
Record Date11/08/1716/02/18
Ex-Div10/08/1715/02/18
Paid11/09/1719/03/18
Amnt68.90133.60
Directors
More ...
Non-Executive Director, ChairmanMr. Leif Johansson
Non-Executive DirectorRudolph Harold Peter Markham
Non-Executive DirectorSherilyn S. McCoy
Executive Director, Chief Financial OfficerMr. Marc Dunoyer
Non-Executive DirectorMr. Marcus Wallenberg
Executive Director, Chief Executive OfficerMr. Pascal Soriot
Non-Executive DirectorPhilip A J Broadley
Non-Executive DirectorMr. Graham Andrew Chipchase
Non-Executive DirectorProf Genevieve Berger
Non-Executive DirectorBaroness Shriti Vadera
Non-Executive DirectorDeborah DiSanzo
Non-Executive DirectorProfessor Nazneen Rahman
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.